CCS(SH:600180)2021-10-29 16:00Financial Performance - The company's operating revenue for Q3 2021 was ¥10,804,227,603.23, representing a year-on-year increase of 16.56%[7] - The net profit attributable to shareholders for Q3 2021 was ¥255,147,332.04, showing a significant increase of 6,022.55% compared to the same period last year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2021 was ¥251,414,147.60, reflecting a year-on-year increase of 291.27%[7] - The basic earnings per share for Q3 2021 was ¥0.2529, an increase of 6,092.02% compared to the same period last year[8] - The diluted earnings per share for Q3 2021 was also ¥0.2529, with the same year-on-year increase of 6,092.02%[8] - Operating profit for the third quarter was ¥612,053,815.46, up from ¥183,037,243.96 in the previous year, reflecting a significant increase of 234.5%[39] - Net profit attributable to shareholders of the parent company for the third quarter was ¥553,484,117.26, compared to ¥151,337,662.41 in the same quarter last year, marking an increase of 264.5%[39] - Total comprehensive income for the period reached CNY 509,038,066.32, a significant increase from CNY 51,548,553.98 in the previous year[42] - Basic and diluted earnings per share were both CNY 0.5471, compared to CNY 0.1489 in the same period last year, reflecting a growth of approximately 267%[42] Assets and Liabilities - Total assets at the end of Q3 2021 amounted to ¥30,740,139,563.55, representing an increase of 8.41% from the end of the previous year[8] - The total assets of the company as of September 30, 2021, are ¥30,740,139,563.55, compared to ¥28,354,625,087.02 in the previous year, reflecting a growth of about 8.4%[29] - The total liabilities increased to ¥24,091,931,108.79 from ¥22,000,000,000.00, indicating a rise of approximately 9.5%[29] - Total liabilities increased to ¥24,189,493,690.49 from ¥22,225,989,151.34, representing an increase of 8.8%[38] - The company’s total liabilities decreased, reflecting improved financial stability and management of debt obligations[48] - Total liabilities reached approximately ¥22.23 billion, with current liabilities at ¥21.92 billion and non-current liabilities at ¥309.88 million[53] Shareholder Information - The total number of common shareholders at the end of the reporting period is 19,168[21] - The largest shareholder, Zhengzhou Ruimaotong Supply Chain Co., Ltd., holds 554,443,265 shares, accounting for 54.55% of total shares[21] - The number of shares held by the top ten shareholders includes significant pledges, with Zhengzhou Ruimaotong pledging 436,380,000 shares[21] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥103,819,568.74, which decreased by 96.99% compared to the same period last year[8] - Cash inflows from operating activities totaled CNY 39,173,170,205.50, up from CNY 32,240,788,025.92, indicating a year-over-year increase of about 21%[46] - Cash outflows from operating activities were CNY 39,069,350,636.76, compared to CNY 28,795,464,177.89 in the previous year, resulting in a net cash flow from operating activities of CNY 103,819,568.74[46] - The net cash flow from investing activities was reported at CNY -60,383,075.70, an improvement from CNY -2,234,850,841.96 in the previous year[48] - Cash inflows from financing activities amounted to CNY 7,732,695,379.20, while cash outflows were CNY 7,628,495,332.56, resulting in a net cash flow from financing activities of CNY 104,200,046.64[48] - The ending balance of cash and cash equivalents was CNY 1,166,112,804.40, compared to CNY 1,148,152,528.20 at the end of the previous year[48] Inventory and Receivables - Accounts receivable increased to ¥10,058,811,941.61 from ¥7,720,874,003.05 year-over-year, indicating a growth of approximately 30.5%[29] - The company reported a significant increase in inventory, which rose to ¥1,578,656,669.98 from ¥941,953,028.37, marking an increase of about 77.5%[32] - The company reported accounts receivable of approximately ¥169.77 million, including interest receivable of ¥61.09 million[50] - Inventory was valued at approximately ¥941.95 million, indicating a significant asset base[50] Research and Development - Research and development expenses for the third quarter amounted to ¥2,341,366.41, with no previous year data provided[37] - The company has not disclosed any new product or technology developments in the current reporting period[28] Mergers and Acquisitions - There are no significant mergers or acquisitions reported during this quarter[28]